• Medientyp: E-Artikel
  • Titel: LXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL Receptor
  • Beteiligte: Zelcer, Noam; Hong, Cynthia; Boyadjian, Rima; Tontonoz, Peter
  • Erschienen: American Association for the Advancement of Science (AAAS), 2009
  • Erschienen in: Science, 325 (2009) 5936, Seite 100-104
  • Sprache: Englisch
  • DOI: 10.1126/science.1168974
  • ISSN: 0036-8075; 1095-9203
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: Idolizing Cholesterol Control The low-density lipoprotein receptor (LDLR) removes LDL, the so-called “bad” cholesterol particles, from the blood through a mechanism that involves LDL binding and internalization into liver cells. Because the LDLR plays a pivotal role in heart disease risk, there is substantial interest in understanding how its expression is regulated, and a large body of previous work has established the importance of transcriptional control. A new study identifies a signaling pathway that appears to regulate the LDLR at the level of protein degradation. Zelcer et al. (p. 100 , published online 11 June) show that a sterol-responsive transcription factor called LXR induces the expression of Idol (for inducible degrader of the LDLR), a protein that triggers ubiquitination of the receptor and targets it for degradation. Activation of this pathway suppresses cellular uptake of LDL and, in a mouse model, leads to higher plasma LDL levels, raising the possibility that the pathway could be targeted pharmacologically to control plasma cholesterol levels.